Hovione Farmaciencia SA 2016 SR
The report highlights Hovione's sustainability performance for the fiscal years 2015 and 2016. During this period, the company achieved B Corp certification, becoming the first chemical and pharmaceutical company to join this community. Hovione made significant progress in waste management, recycling, reusing, or recovering 88% of its waste in FY2016. The company also initiated pilot testing of electroperoxicoagulation (EPC) technology to treat pharmaceutical wastewater and destroy active pharmaceutical ingredients. Additionally, Hovione expanded its workforce to 1,350 employees and invested in local communities through various social and educational projects.
Company: Hovione Farmaciencia SA
Sector: Manufacturing
Country: Portugal
Year: 2016
Type: SR
Pages: 72
Back to company
Hovione Farmaciencia SA
Sustainability Report
The report highlights Hovione's sustainability performance for the fiscal years 2015 and 2016. During this period, the company achieved B Corp certification, becoming the first chemical and pharmaceutical company to join this community. Hovione made significant progress in waste management, recycling, reusing, or recovering 88% of its waste in FY2016. The company also initiated pilot testing of electroperoxicoagulation (EPC) technology to treat pharmaceutical wastewater and destroy active pharmaceutical ingredients. Additionally, Hovione expanded its workforce to 1,350 employees and invested in local communities through various social and educational projects.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Apr 1, 2015 - Mar 31, 2017
Fiscal Year
2016
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Employees